Coping Strategies for Chronic Pain
Trial Summary
Do I have to stop taking my current medications for this trial?
The trial does not specify if you need to stop taking your current medications. However, since the study involves opioid use, you may need to continue your prescription opioids as part of the trial.
What data supports the idea that Coping Strategies for Chronic Pain is an effective treatment?
The available research shows that Coping Strategies for Chronic Pain, like Cognitive Behavioral Therapy (CBT), are effective in improving pain and related problems for people with chronic pain. Multiple studies have shown that CBT helps people manage their pain better, and it has been beneficial for different groups, including children and older adults. Additionally, CBT has been adapted to be delivered in various ways, such as online or over the phone, making it more accessible. Compared to other treatments, CBT is supported by evidence from many trials, showing it can improve how people function and reduce their need for healthcare.12345
What safety data exists for CBT in treating chronic pain?
Cognitive behavioral therapy (CBT) for chronic pain is considered a safe and effective treatment alternative to opioid analgesics. Multiple studies, including randomized controlled trials, support its efficacy and safety across various chronic pain conditions and populations, such as children and older adults. Innovations in delivery methods, like internet-based CBT, have also been explored to improve access and maintain safety.14678
Is the treatment in the trial 'Coping Strategies for Chronic Pain' a promising treatment?
Yes, coping strategies are promising for managing chronic pain. They help people handle pain by using different methods like cognitive (thinking), behavioral (actions), and social (interactions) strategies. These strategies can improve how people function and feel, making them a valuable approach for those dealing with chronic pain.123910
What is the purpose of this trial?
Adherence to prescription opioid and opioid tapering as indicated are critical for safe chronic opioid therapy for chronic pain, but this can be difficult for patients experiencing prescription opioid craving. Because pain catastrophizing is proposed as a possible treatment target by our and others' preliminary results, the proposed study aims to determine whether pain catastrophizing is a treatment target to reduce prescription opioid craving and to investigate whether negative affect and stress hormones are potential mediators. The findings from the current study will inform whether a psychology intervention to lower pain catastrophizing will reduce opioid craving, and whether psychological and physical distress as well as cognitive function will be potential mediators of the treatment effect.
Research Team
Dokyoung S You, PhD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for adults over 18 with chronic pain lasting more than 3 months who have been using prescription opioids. Participants must speak English and have access to email or a smartphone. People with cancer, severe psychiatric conditions, concurrent psychological therapy, skin conditions on the hand, or without technology access cannot join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants practice pain coping statements daily for 7 days to reduce pain catastrophizing
Monitoring
Participants' opioid craving, opioid use, and negative affect are monitored daily
Follow-up
Participants are monitored for safety and effectiveness after intervention
Treatment Details
Interventions
- Coping Statement
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Collaborator